Publications

2014
Working Paper

Bridging Science and Technology Through Academic-Industry Partnerships

By: Sen Chai and Willy C. Shih

Scientific research and its translation into commercialized technology is a driver of wealth creation and economic growth. Partnerships to foster the translational processes from public research organizations, such as universities and hospitals, to private firms are a... View Details

Keywords: Innovation; Firm Performance; Public-private Partnership Funding; Translational Research; Small And Medium Enterprises; Partners and Partnerships; Public Sector; Private Sector; Performance; Science-Based Business; Innovation and Invention

SSRN

Article

Policies to Influence Perceptions about COVID-19 Risk: The Case of Maps

By: Claudia Engel, Jonathan Rodden and Marco Tabellini

Choropleth disease maps have become an important tool for informing the public about the risks posed by COVID-19. In a survey conducted in the U.S. state of Georgia in June 2020, we randomly assigned respondents to view either of two maps. The first one reported... View Details

Keywords: Disease Surveillance; Health Pandemics; Risk and Uncertainty; Perception; Policy

Research Summary

Managing sustainability in supply chains

By: Michael W. Toffel

I am examining codes of conduct, management process standards, and government voluntary programs that address environmental and labor issues, seeking to understand what enables some of these programs to actually deliver on their promise of distinguishing organizations... View Details

Keywords: Environment; Environmental Performance; Environmental Regulation; Environmental Strategy; Regulation; Supply Chain; Supply Chain Management; Manufacturing Industry; Auto Industry; Service Industry; Construction Industry; United States; California

08 May 2023
Research & Ideas

How Trump’s Anti-Immigrant Rhetoric Crushed Crowdfunding for Minority Entrepreneurs

but that gap triples during periods of high public anxiety over immigration in the United States. “When there is the greatest anxiety, we see this funding shortfall.” Banks have historically rejected loan applications from Black, Asian,... View Details

Keywords: by Scott Van Voorhis

27 Jun 2016
News

Food Stamp Entrepreneurs

26 Nov 2013
First Look

First Look: November 26

Publications August 2013 Journal of Corporate Finance Golden Parachutes and the Wealth of Shareholders By: Bebchuk, Lucian A., Alma Cohen, and Charles C.Y. Wang Abstract—Golden parachutes (GPs) have attracted substantial attention from... View Details

Keywords: Sean Silverthorne

29 Oct 2015
News

Options to Promote Competitive Generics Markets in the United States

Research Summary

Evolution of the Global Beauty Industry

By: Geoffrey G. Jones

This research examines the global beauty industry, which includes cosmetics, deodorants, fragrances, hair care, oral hygiene and skin care. Today global sales of cosmetics and toiletries are in excess of U.S. $380 billion. This research examines the growth of this... View Details

20 Nov 2018
First Look

New Research and Ideas, November 20, 2018

Abstract—In a survey of the NEJM Catalyst Insights Council in July 2018, 42% of respondents say they think value-based reimbursement models will be the primary revenue model for U.S. health care. Indeed, this transition is already... View Details

Keywords: Dina Gerdeman

2018
Book

Food Citizenship: Food System Advocates in an Era of Distrust

By: Ray A. Goldberg

The global food system is the largest segment of the world's economy. As agribusiness-studies pioneer Ray Goldberg suggests, it is also the largest health system on the planet. And it is changing fast. Its size and importance to human, environmental, and economic... View Details

Keywords: Food; System; Global Range; Health; Environmental Sustainability; Development Economics; Partners and Partnerships; Public Opinion; Agriculture and Agribusiness Industry; Food and Beverage Industry

Find at Harvard

Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details

Keywords: health care; health care; health care; health care; health care; health care; health care; health care

2020
Working Paper

What Can Economics Say About Alzheimer's Disease?

By: Amitabh Chandra, Courtney Coile and Corina Mommaerts

Alzheimer’s Disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the... View Details

Keywords: Health Disorders; Health Care and Treatment; Economics

April 2006
Case

Medical Innovation Beyond MedStar: Mobilizing for National Impact

By: Rosabeth M. Kanter, Ryan Raffaelli and Michelle Heskett

Dr. Craig Feied, director of MedStar Health's Medical Informatics programs, wanted his innovations to influence national health care. Since joining Washington Hospital Center's Emergency Department in 1995 with Dr. Mark Smith, their information system had become the... View Details

Keywords: Collaborative Innovation and Invention; Innovation Strategy; Technological Innovation; Policy; Government and Politics; Innovation and Management; Projects; Corporate Social Responsibility and Impact; Health Industry; Health Industry; Washington (state, US)

29 Jan 2019
Research & Ideas

'Green Bonds' May Be Our Best Bet for Environmental Damage Control

Municipalities have been selling bonds to pay for public works projects—fire stations, parking garages,sewage treatment systems—for 200 years. It’s only in the past decade or so, however, that they’ve been selling them with an extra perk: helping the environment. In... View Details

Keywords: by Michael Blanding; Energy; Utilities; Construction; Green Technology; Public Administration

Teaching Interest

Managing Global Health: Applying Behavioral Economics to Create Impact (MBA)

Health, and development more broadly, is not something we give to people: it is something they produce themselves, interacting with supply-side and institutional factors. This course trains students to see through the lens of the end-user and to use the levers of... View Details

March 2014 (Revised November 2020)
Case

The Novartis Malaria Initiative

By: Michael Chu, Vincent Marie Dessain and Emilie Billaud

The Novartis Malaria Initiative was designed, as a result of a precedent–setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria—"at no profit"—for public health systems. What had begun as an exemplary act of... View Details

Keywords: Health Care and Treatment; Product Marketing; Corporate Social Responsibility and Impact; Social Enterprise; Pharmaceutical Industry; Switzerland; Africa; Nigeria

September 2006 (Revised November 2007)
Case

Patrimonio Hoy: A Financial Perspective

By: Arthur I Segel, Michael Chu and Gustavo A. Herrero

Patrimonio Hoy, a program targeting the housing needs of low-income families launched by CEMEX, a major Mexican corporation and a leading global cement company, has gone from a market research project to a highly visible initiative in 22 cities and has earned public... View Details

Keywords: Diversification; Housing; Income; Corporate Social Responsibility and Impact; Emerging Markets; Finance; Mexico

09 Mar 2015
Research & Ideas

Why Entrepreneurs Should Go Work for Government

School who has created a new MBA course, Public Entrepreneurship. "The course allows students to consider the alternative that government can work—or they can help make it work." “We have many talented people in government, but... View Details

Keywords: by Michael Blanding

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry

Find at Harvard